Inventor · disambiguated record
Steve Holmes
Also filed as: HOLMES STEVE · HOLMES STEVE J
42 granted patents·23 pending applications·328 citations·filing 1988–2025
98Inventor score
Top patents by PatentIndex Score
65 records- 0198US9234043B1Anti-human OX40L antibodiesKYMAB LTD·Filed 2015·Granted Jan 12, 2016·21 cites·20 claims
- 0298US9139653B1Anti-human OX40L antibodies and methods of treatmentKYMAB LTD·Filed 2015·Granted Sep 22, 2015·38 cites·27 claims
- 0397US9512229B2Synergistic combinations of OX40L antibodies for the treatment of GVHDKYMAB LTD·Filed 2016·Granted Dec 6, 2016·12 cites·30 claims
- 0496US9868790B2Synergistic combinations of OX40L antibodies for the treatment of GvHDKYMAB LTD·Filed 2017·Granted Jan 16, 2018·11 cites·29 claims
- 0596US9868789B2Synergistic combinations of OX40L antibodies for the treatment of GvHDKYMAB LTD·Filed 2017·Granted Jan 16, 2018·11 cites·19 claims
- 0695US9705077B2Spin torque MRAM fabrication using negative tone lithography and ion beam etchingIBM·Filed 2015·Granted Jul 11, 2017·7 cites·16 claims
- 0794US11396550B2Methods of treating comprising administering anti-OX40L antibodiesKYMAB LTD·Filed 2017·Granted Jul 26, 2022·4 cites·54 claims
- 0894US10654935B2Methods of treating SLE with anti-OX40L antibodiesKYMAB LTD·Filed 2016·Granted May 19, 2020·7 cites·13 claims
- 0994US9587030B2Anti-hOX40L antibodies, uses, and methodsKYMAB LTD·Filed 2016·Granted Mar 7, 2017·14 cites·21 claims
- 1093US10669342B2Anti-OX40L antibodies and methods of treating graft versus host diseaseKYMAB LTD·Filed 2015·Granted Jun 2, 2020·7 cites·14 claims
- 1193US9490164B1Techniques for forming contacts for active BEOLIBM·Filed 2015·Granted Nov 8, 2016·10 cites·20 claims
- 1293US9434785B1Anti-human OX40L antibodies and methods of treating graft versus host disease with the sameKYMAB LTD·Filed 2015·Granted Sep 6, 2016·16 cites·30 claims
- 1393US8454959B2Compositions monovalent for CD28 binding and methods of useMCKINNON MURRAY·Filed 2012·Granted Jun 4, 2013·23 cites·11 claims
- 1493US8168759B2Compositions monovalent for CD28 binding and methods of useMCKINNON MURRAY·Filed 2009·Granted May 1, 2012·21 cites·13 claims
- 1592US9085629B2Compositions monovalent for CD28 binding and methods of useMCKINNON MURRAY·Filed 2012·Granted Jul 21, 2015·18 cites·29 claims
- 1692US7696320B2Ligands that have binding specificity for VEGF and/or EGFR and methods of use thereforDOMANTIS LTD·Filed 2006·Granted Apr 13, 2010·25 cites·65 claims
- 1791US11773175B2Antibodies, uses and methodsKYMAB LTD·Filed 2021·Granted Oct 3, 2023·1 cites·19 claims
- 1891US10919965B2Compositions monovalent for CD28 binding and methods of useBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 16, 2021·3 cites·18 claims
- 1988US9908937B2Compositions monovalent for CD28 binding and methods of useBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Mar 6, 2018·5 cites·22 claims
- 2088US2024132605A1Antibodies, uses & methodsKYMAB LTD·Filed 2023·Application pending·0 cites
- 2187US8497244B2Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissueDE WILDT RUDOLF M T·Filed 2012·Granted Jul 30, 2013·12 cites·6 claims
- 2287US8129503B2Agents that bind a target in pulmonary tissue for targeting respiratory diseasesDE WILDT RUDOLF M T·Filed 2006·Granted Mar 6, 2012·11 cites·6 claims
- 2381US11312781B2Antigen binding molecules that bind LIGHTCAPELLA BIOSCIENCE LTD·Filed 2019·Granted Apr 26, 2022·2 cites·21 claims
- 2479US10259880B2Anti-LIGHT antibodiesKYMAB LTD·Filed 2015·Granted Apr 16, 2019·3 cites·30 claims
- 2579US2025263492A1Antibodies, uses & methodsKYMAB LTD·Filed 2025·Application pending·0 cites
- 2678US11753479B2Nucleic acids encoding anti-OX40L antibodiesKYMAB LTD·Filed 2020·Granted Sep 12, 2023·0 cites·21 claims
- 2778US10714341B2Reactive ion etching assisted lift-off processes for fabricating thick metallization patterns with tight pitchELPIS TECH INC·Filed 2017·Granted Jul 14, 2020·2 cites·20 claims
- 2876US12012452B2Compositions monovalent for CD28 binding and methods of useBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jun 18, 2024·0 cites·20 claims
- 2975US9629909B2Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissueDOMANTIS LTD·Filed 2013·Granted Apr 25, 2017·2 cites·70 claims
- 3074US2024294655A1Antigen binding molecules that bind lightCENTESSA PHARMACEUTICALS UK LTD·Filed 2023·Application pending·0 cites
- 3170US12473371B2Anti-OPG antibodiesKYMAB LTD·Filed 2023·Granted Nov 18, 2025·0 cites·3 claims
- 3270US11164992B2Device with integration of light-emitting diode, light sensor, and bio-electrode sensors on a substrateIBM·Filed 2019·Granted Nov 2, 2021·0 cites·14 claims
- 3369US12227580B2Antigen binding molecules that bind LIGHTCENTESSA PHARMACEUTICALS UK LTD·Filed 2022·Granted Feb 18, 2025·0 cites·24 claims
- 3469US2019276547A1Antibodies, uses & methodsKYMAB LTD·Filed 2018·Application pending·0 cites
- 3566US6190829B1Low “K” factor hybrid photoresistIBM·Filed 1996·Granted Feb 20, 2001·24 cites·10 claims
- 3665US9028822B2Antagonists against TNFR1 and methods of use thereforBREWIS NEIL D·Filed 2011·Granted May 12, 2015·3 cites·12 claims
- 3763US11827673B2Antigen binding molecules that bind lightCAPELLA BIOSCIENCE LTD·Filed 2018·Granted Nov 28, 2023·0 cites·12 claims
- 3863US2008233129A1Ligand that has binding specificity for IL-4 and/or lL-13TOMLINSON IAN M·Filed 2008·Application pending·0 cites
- 3963US2008233130A1Ligand that has binding specificity for IL-4 and/or IL-13TOMLINSON IAN M·Filed 2008·Application pending·0 cites
- 4062US10388857B2Spin torque MRAM fabrication using negative tone lithography and ion beam etchingIBM·Filed 2016·Granted Aug 20, 2019·1 cites·8 claims
- 4161US2022372153A1Synergistic combinations of ox40l antibodies for the treatment of gvhdKYMAB LTD·Filed 2022·Application pending·0 cites
- 4260US2017037137A1Synergistic combinations of ox40l antibodies for the treatment of gvhdKYMAB LTD·Filed 2016·Application pending·0 cites
- 4359US10566493B1Device with integration of light-emitting diode, light sensor, and bio-electrode sensors on a substrateIBM·Filed 2018·Granted Feb 18, 2020·0 cites·7 claims
- 4457US11680101B2Anti-OPG antibodiesKYMAB LTD·Filed 2018·Granted Jun 20, 2023·0 cites·17 claims
- 4557US2007104710A1Ligand that has binding specificity for IL-4 and/or IL-13DOMANTS LTD·Filed 2006·Application pending·0 cites
- 4656US9109031B2Ligands that bind TGF-β receptor RIIDIMECH CAROLINE J·Filed 2010·Granted Aug 18, 2015·1 cites·16 claims
- 4756US2009081233A1Ligands that have binding specificity for VEGF and/or EGFR and methods of use thereforDOMANTIS LTD·Filed 2008·Application pending·0 cites
- 4855US2022162322A1Anti bdca-2 antibodiesCAPELLA BIOSCIENCE LTD·Filed 2022·Application pending·0 cites
- 4954US10763429B2Self-aligned ion beam etch sputter mask for magnetoresistive random access memoryIBM·Filed 2018·Granted Sep 1, 2020·0 cites·12 claims
- 5054US2017210814A1Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissueDOMANTIS LTD·Filed 2017·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Steve Holmes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →